The innovation and development of the traditional Chinese medicine industry requires both "soft and hard"

In recent years, China has not issued a series of policies to support the development of traditional Chinese medicine, including "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics", "Opinions on Further Strengthening the Work of Traditional Chinese Medicine in General Hospitals to Promote the Coordinated Development of Chinese and Western Medicine", " Implementation Plan of Traditional Chinese Medicine Culture Dissemination Action (2021-2025), "14th Five-Year Plan for National Drug Safety and Promotion of High-Quality Development",
etc.
The innovation and development of the Chinese medicine industry requires both "soft and hard" (Photo source: Pharmaceutical Network) With the support of a series of favorable policies, the development and prospects of the Chinese medicine industry are being valued and optimistic by the industry
.
Analysts predict that in 2022, the innovation vitality and potential of traditional Chinese medicine will continue to be released, and the innovative achievements of traditional Chinese medicine will continue to emerge
.
In fact, since the beginning of this year, a number of new Chinese medicines have been successfully approved for marketing
.
For example, on January 10, the State Food and Drug Administration announced that the State Food and Drug Administration recently approved the 1.
2 category innovative drug icariin soft capsules with conditions through the priority review and approval process
.
The drug will be used to treat liver cancer
.
This is also the first innovative traditional Chinese medicine drug approved for marketing in China since 2022
.
However, with the rapid development of the Chinese medicine industry, it is also necessary to see that it is not a simple matter to do a good job in maintaining the integrity, innovation, inheritance and development of traditional Chinese medicine
.
In view of the current situation, there are still many challenges to strengthen traditional Chinese medicine, such as the shortage of high-level talents in traditional Chinese medicine, the low level of scientific and technological research and development, the imperfect service system, and the insufficient development of traditional Chinese medicine culture
.
Among them, the traditional Chinese medicine industry in particular has been facing the difficulty of innovation, and the research and development generally faces the problems of unclear mechanism of action and unclear active ingredients, which is seriously hindering the pace of inheritance, innovation and development of traditional Chinese medicine
.
In this regard, industry insiders pointed out that in order to seize the opportunity and better develop the traditional Chinese medicine industry, relevant companies need to grasp both soft and hard
.
First of all, it is necessary to continuously improve the quality and innovation; secondly, the publicity, promotion and management of traditional Chinese medicine should also be strengthened
.
In terms of hard power, in fact, a large number of traditional Chinese medicine companies have begun to actively deploy high-tech medicine, and strive to use modern technology to empower traditional Chinese medicine and accelerate innovation.

.
For example, on January 7, 2022, when Liuyao responded to investors on the interactive platform, it stated that the company would continue to increase investment in the layout of the Chinese medicine sector, continue to improve its technical capabilities in the field of Chinese medicine decoction pieces, and promote the digital upgrade of the industry.
Launched a Chinese medicine traceability platform, and carried out related patent application and implementation applications such as identification, processing, and production of traditional Chinese medicines
.
At the same time, it also stated that it will accelerate the research and development of products in related fields in terms of traditional Chinese medicine innovation, and continuously improve the added value of products
.
In addition, at the end of 2021, Buchang Pharmaceutical also revealed that the company will continue to vigorously promote the building of traditional Chinese medicine brands in the future to help promote traditional Chinese medicine to the world
.
"It is necessary to improve the level of modernization, modernize production methods, and at the same time use Western clinical theories to improve the scientific and technological content of traditional Chinese medicine, and tell the world about the efficacy and rationale of traditional Chinese medicine
.
" In the future, intelligent and information-based hardware equipment will better help pharmacies and pharmaceutical enterprises to manage their production and management more efficiently and conveniently, and reduce costs; and software upgrades will also help traditional Chinese medicine enterprises in maintaining equipment, managing equipment, marketing, and services.
and more to gain more
.
It is worth mentioning that the software and hardware upgrades of traditional Chinese medicine enterprises are also inseparable from the support of upstream equipment manufacturers in the industry chain.
Therefore, with the accelerated development of the traditional Chinese medicine industry, the industry expects that the upstream traditional Chinese medicine pharmaceutical equipment industry will also usher in more opportunities
.